
Thomas Sherrer, PharmD, co-owner of Poole's Pharmacy, describes implementing multiple tracking methods to stay ahead of drug shortages.
Thomas Sherrer, PharmD, co-owner of Poole's Pharmacy, describes implementing multiple tracking methods to stay ahead of drug shortages.
Crystal Lennartz, president of Health Mart & Health Mart Atlas at McKesson, discusses challenges that independent pharmacies are facing in today's health care landscape.
Jeanine Singer, senior vice president of national and key accounts at McKesson, discusses the company's approach to empowering pharmacists and strengthening the community pharmacy ecosystem.
Through platforms like Health Mart Atlas, the company is providing pharmacies with tools to better understand their financial landscape.
Thomas Sherrer, PharmD, emphasizes the importance of a team-based approach to inventory control.
Buddy Carter, PBM, US Representative (R-GA), emphasizes the critical role of pharmacists, particularly during the COVID-19 pandemic, and advocates for provider status recognition.
In part 3 of our interview with Iowa State Representative Brett Barker, PharmD, he discusses how legislation at the state level is gradually informing decisions at the federal level.
Brett Barker, PharmD, State Representative in Iowa’s 51st District, discussed Senate File 383 and how it’s intended to impact Iowa pharmacies.
Walgreens Chief Pharmacy Officer Rick Gates discusses ongoing movement at the state level regarding pharmacy benefit manager reform.
Jon Easter, RPh, discusses pharmacists’ ability to improve patient engagement in diabetes care following his presentation at the American Diabetes Association’s 85th Scientific Sessions.
Jon Easter, RPh, joined Drug Topics to discuss pharmacists’ roles within health care teams following his presentation at the American Diabetes Association’s 85th Scientific Sessions.
Nathan Ramsbacher, PharmD, emphasizes that one of the most significant barriers to clinical quality is patients' inability to access crucial medications due to cost.
The initiative focuses on managing medications for high-risk diabetes patients through a collaborative drug therapy agreement.
Taylor Watterson, PharmD, PhD, discusses how distress experienced by pharmacy technicians can impact the overall safety and quality of pharmacy operations.
Pharmaceutical Strategies Group experts joined Drug Topics to discuss the role GLP-1s play in drug benefit design.
Nicole Cieri-Hutcherson, PharmD, BCPS, MSCP, FCCP, discusses how pharmacists can support patient counseling and education around medication abortion.
At the Total Pharmacy Solutions Summit Summer 2025 event, Stephanie Zimmerman, Tom Napolitano, and Luke Gunderson discussed the benefits of Real Value RX.
Kevin Cleveland, PharmD, discusses how pharmacists are uniquely positioned to directly interact with patients, making them vital in addressing vaccine misinformation.
Tara Pfund, PharmD, chief strategy officer with the Cascadia Pharmacy Group, discusses a variety of ways community pharmacists can expand services and support clinical reimbursement.
Heidi Polek, RPh, EMBA, discusses how pharmacies must adopt strategic approaches to maintain financial health and continue providing patient care.
Emily Endres, BSPS, and Todd Sega, PharmD, MBA, discuss pressures that pharmacies are currently facing, including reimbursements, competition, and patient needs.
Nicole Cieri-Hutcherson, PharmD, BCPS, MSCP, FCCP, discusses how pharmacist involvement in medication abortion can improve reproductive health care access.
John Hill, MBAHCM, and Pooja Babbrah, MBA, from the National Council for Prescription Drug Programs, discuss their organization’s strategic plan for advancing the pharmacy profession.
Morgan Lee, PhD, MPH, CPH, and Scott Halperin, PharmD, from the Pharmaceutical Strategies Group, discuss the 2025 Trends in Drug Benefit Design Report and how it will impact pharmacists.
Laura Knockel, PharmD, BCACP, expresses concerns about how vaccine recommendations are being communicated, noting a shift away from traditional, transparent discussions to less formal channels such as social media.
Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, highlights the critical role pharmacists play in navigating vaccine recommendations and supporting patient understanding.
Deanna Tran, PharmD, BCACP, FAPhA, emphasizes community outreach, especially in areas with high vaccine hesitancy, as a crucial strategy for maintaining public trust in vaccination programs.
Pharmacists stress that rebuilding trust is challenging and requires careful, empathetic communication.
Taylor Watterson, PharmD, PhD, discusses what a truly inclusive and technician-centered pharmacy looks like and what it takes to get there.
Taylor Watterson, PharmD, PhD, discusses how to recognize the contribution of pharmacy technicians in day-to-day operations.